首页 | 本学科首页   官方微博 | 高级检索  
     

印度医药企业新药研发经验启示
引用本文:茅宁莹. 印度医药企业新药研发经验启示[J]. 中国药房, 2005, 16(18): 1369-1372
作者姓名:茅宁莹
作者单位:中国药科大学国际医药商学院,南京市,210038
摘    要:目的:培育和发展我国医药企业的新药研发能力。方法:分析印度医药企业在新药研发方面的经验。结果与结论:我国医药企业培育新药研发能力,不仅要在战略上重视新药研发的价值,更要在加强外部合作、吸引海外人才及培育整合能力等方面,积极探索有效的方法和措施。

关 键 词:印度  医药企业  新药  研究与开发  创新
文章编号:1001-0408(2005)18-1369-04
收稿时间:2005-05-18
修稿时间:2005-08-05

The Enlightenment from the Experiences on Research & Development of New Drugs in Indian Pharmaceutical Enterprises
MAO Ningying. The Enlightenment from the Experiences on Research & Development of New Drugs in Indian Pharmaceutical Enterprises[J]. China Pharmacy, 2005, 16(18): 1369-1372
Authors:MAO Ningying
Affiliation:The International Pharmaceutical Business School, China Pharmaceutical University, Nanjing 210038, China
Abstract:OBJECTIVE:To cultiveate and development of Research &Development(R &D)abilities for new drugs for Chinese pharmaceutical enterprises.METHODS:The experiences on new drugs' R&D of some Indian pharmaceutical enterprises were analyzed.RESULTS &CONCLUSION:To improve R &D abilities for new drugs,Chinese pharmaceutical enterprise should try to explore effective ways and measures by not only emphasizing the strategic value of R&D for new drugs,but also strengthening the cooperation with outside,attracting the overseas talents,cultivating the integrative capa-bility,etc.
Keywords:India  Pharmaceutical enterprises  New drug  Research &Development  Innovation
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号